Serotoninergic Mechanisms of Immunomodulation Under Different Psychoemotional States: I. A role of 5-HT_1a Receptor Subtype

REFERENCES

• Aune T. M., Golden H. W., McGrath K. K. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivi. Journal of Immunology 1994; 153: 489–498
   PubMed Web of Science ®Google Scholar
• Barnes N. M., Sharp T. A review of central 5-HT1A receptors and their function. Neuropharmacology 1999; 38: 1083–1152
   PubMed Web of Science ®Google Scholar
• Blanchard D. C., Griebel G., Rodgers R. J., Blanchard R. J. Benzodiazepine and serotoninergic modulation of antipredator and conspecific defense. Neuroscience Biobehavioral Review 1998; 22: 597–612
   PubMedGoogle Scholar
• Cunningham A. J. A method of increased sensitivity for detecting single antibody forming cell. Nature 1965; 207: 1106–1107
   PubMed Web of Science ®Google Scholar
• Devoino L., Alperina E., Idova G. Dopaminergic stimulation of the immune reaction: Interaction of serotoninergic and dopaminergic systems in neuroimmunomodulation. International Journal of Neuroscience 1988; 40: 271–288
   PubMed Web of Science ®Google Scholar
• Devoino L., Alperina E., Kudryavtseva N., Popova N. Immune responses in male mice with aggressive and submissive behavior patterns: Strain differences. Brain, Behavior, and Immunity 1993; 7: 91–96
   PubMed Web of Science ®Google Scholar
• Devoino L. V., Alperina E. L., Podgornaya E. K., Polyakov O. V., Idova G. V., Ilyutchenok R. Y. Brain content of 5- hydroxytryptamine and 5-hydroxyindoleacetic acid and immune response in aggressive C57Bl/6J mice. Bulletin of Experimental Biology and Medicine 2000; 130: 954–956, [in Russian]
   Google Scholar
• Devoino L., Alperina E., Pavina T. Immunological consequences of the reversal of social status in C57BL/6J mice. Brain, Behavior, and Immunity 2003a; 17: 28–34
   PubMedGoogle Scholar
• Devoino L. V., Alperina E. L., Podgornaya E. K., Polyakov O. V., Idova G. V., Ilyutchenok R. Y. Nature of the distribution of serotonin and a serotonin metabolite in brain structures and the development of immunosuppression in submissive mice. Neuroscience and Behavioral Physiology 2003b; 33: 473–477
   Google Scholar
• Devoino L., Idova G., Alperina E., Cheido M. Brain neuromediator systems in the immune response control: Pharmacological analysis of pre- and postsynaptic mechanisms. Brain Research 1994; 633: 267–274
   PubMed Web of Science ®Google Scholar
• Gartner K., Kirchhoff H., Mensing K., Velleuer R. The influence of social rank on the susceptibility of rats to mycoplasma arthritis. Journal of Behavioral Medicine 1989; 12: 487–502
   Google Scholar
• Gasparotto O. C., Ignacio Z. M., Lin K., Goncalves S. The effect of different psychological profiles and timings of stress exposure on humoral immune response. Physiology and Behavior 2002; 76: 321–327
   PubMed Web of Science ®Google Scholar
• Graeff F. G., Viana M. B., Mora P. O. Dual role of 5-HT1A in defense and anxiety. Neuroscience Biobehavioral Review 1997; 21: 791–799
   PubMedGoogle Scholar
• Haller J., Kiem D. T., Makara G. B. Physiology of social conflict in rats: what is particularly stressful. Behavioral Neuroscience 1996; 140: 353–359
   Google Scholar
• Hennig J., Becher H., Netker P. 5-HT agonist-induced changes in peripheral immune cells in healthy volunteers: The impact of personality. Behavioral Brain Research 1996; 73: 359–363
   PubMed Web of Science ®Google Scholar
• Hoyer D., Clarke D. E., Fazard J. R., Harting P. R., Martin G. R., Mylecharane E. J., Saxena P. R., Humphrey P. P. International union of pharmacology of classification of receptor for 5-hydrotryptamine(serotonin). Pharmacology Review 1994; 46: 157–203
   PubMed Web of Science ®Google Scholar
• Idova G. V., Cheido M. A., Devoino L. V. Modulation of the immune response by changing neuromediator system activity under stress. International Journal of Immunopharmacology 1997; 19: 535–540
   PubMed Web of Science ®Google Scholar
• Idova G. V., Cheido M. A., Zhukova E. N., Devoino L. V. Stimulation of the immune response during activation of the dopaminergic system in mice with opposite types of behavior. Neuroscience and Behavioral Physiology 2004; 34: 417–421
   Google Scholar
• Idova G. V., Davydova S. M., Cheido M. A. Activation and blocking of 5-HT1A receptors influence on the immune response in CBA mice. Experimental and Clinical Pharmacology 2005; 68(1)42–44, [in Russian]
   Google Scholar
• Idova G. V., Pavina T. A., Alperina E. L., Devoino L. V. Influence of aggressive and submissive behavior on the change in the number of CD4+ and CD8+ T-lymphocyte in the bone marrow. Immunology 2000; 1: 24–26, [in Russian]
   Google Scholar
• Iken K., Chheng S., Fargin A., Goulet A. C., Kouassi E. Serotonin upregulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors. Cellular Immunology 1995; 163: 1–9
   PubMed Web of Science ®Google Scholar
• Irvin M. Psychoneuroimmunology of depression: Clinical implications. Brain, Behavior, and Immunity 2002; 16: 1–16
   Google Scholar
• Kiecolt-Glaser J. K. Stress, personal relationship, and immune function: Health implications. Brain, Behavior, and Immunity 1999; 13: 61–72
   PubMed Web of Science ®Google Scholar
• Kudryavtseva N., Bakshtanovskaya I. Neurochemical control of aggression and submission. Zhurnal of Vysshei Nervnoi Deyatel’nosti 1991; 41: 459–466, [in Russian]
   Google Scholar
• Merlot E., Moze E., Bartolomucci A., Dantzer R., Neveu P. J. The rank assessed in food competition test influences subsequent reactivity to immune and social challenges in mice. Brain, Behavior, and Immunity 2004; 18: 468–475
   Google Scholar
• Moynihan J. A., Ader R. Psychoneuroimmunology: Animal models of disease. Psychosomatic Medicine 1996; 58: 546–558
   Google Scholar
• Nomikos G. G., Arboreling L., Hook B. B., Hacksell U., Svensson T. H. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum. Journal of Neural Transmission 1996; 103: 541–554
   Google Scholar
• Pellegrino T. C., Bayer B. M. Role of central 5-HT2 receptors in fluoxetine-induced decreases in T lymphocyte activity. Brain, Behavior, and Immunity 2002; 16: 87–103
   PubMed Web of Science ®Google Scholar
• Popova N. K. From genes to aggressive behavior: the role of serotoninergic system. Bio 2006
   Google Scholar
• Popova N. K., Avgustinovich D. F., Kolpakov V. G., Plyusnina I. Z. Specific [3H] 8-OH-DPAT binding in brain regions of rats genetically predisposed to various defense behavior strategies. Pharmacology, Biochemistry, and Behavior 1998; 59: 793–797
   Google Scholar
• Serres F., Muma N. A., Raap D. K., Garcia F., Battaglia G. Coadministration of 5-hydroxytryptamine (1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic—hydroxytryptamine (1A) receptors in hypothalamus. The Journal of Pharmacology and Experimental Therapeutics 2000; 294: 296–301
   Google Scholar
• Schiepers O. J., Wichers M. C., Maes M. Cytokines and major depression. Progress of Neuropsychopharmacology & Biologic Psychiatry 2005; 29: 201–217
   PubMed Web of Science ®Google Scholar
• Stefanski V. Social stress in laboratory rats: Hormonal responses and immune cell distribution. Psychoneuroendocrinology 2000; 25: 389–406
   Google Scholar
• Summers C. H., Larson E. T., Summers T. R., Renner K. J., Grenberg N. Regional and temporal separation of serotonergic activity mediating social stress. Journal of Neuroscience 1998; 87: 489–496
   Google Scholar
• Vegas O., Fano E., Brain P. F., Alonso A., Azpiroz A. Social stress, coping strategies and tumor development in male mice: Behavioral, neuroendocrine and immunological implications. Psychoneuroendocrinology 2006; 31: 69–79
   PubMed Web of Science ®Google Scholar
• Vishneveckaya G., Plyusnina I., Popova N. Involvement of 5-HT1A receptors on regulation different type of behavior. Zhurnal Vysshei Nervnoi Deyatel’nosti 2001; 51: 704–708 [in Russian]
   Google Scholar
• Yamada J., Sugimoto Y., Horisaka K. The behavioral effect of 8-OH-DPAT in mice. European Journal of Pharmacology 1988; 154: 299–304
   PubMedGoogle Scholar